To formalize and sign the agreement, Udo J. Vetter, ITM Supervisory Board Chairman, Oliver Buck, ITM co-founder and Supervisory Board member, Dr. Mark Harfensteller, COO of ITM, and Dr. Sebastian Marx, CBO of ITM, Prof. Thomas F. Hofmann, President of the TUM, and Prof. Dr. med. Stephanie Combs, Dean of TUM School of Medicine and Health and Member of the Board of University Hospital met on September 26 and toured ITM’s NOVA Lutetium-177 production site in Neufahrn.
To formalize and sign the agreement, Udo J. Vetter, ITM Supervisory Board Chairman, Oliver Buck, ITM co-founder and Supervisory Board member, Dr. Mark Harfensteller, COO of ITM, and Dr. Sebastian Marx, CBO of ITM, Prof. Thomas F. Hofmann, President of the TUM, and Prof. Dr. med. Stephanie Combs, Dean of TUM School of Medicine and Health and Member of the Board of University Hospital met on September 26 and toured ITM’s NOVA Lutetium-177 production site in Neufahrn.